P. J. Adam, R. Boyd, K. L. Tyson, G. C. Fletcher, A. Stamps et al., Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer, The Journal of biological chemistry, vol.278, pp.6482-6489, 2003.

M. J. Bissell and W. C. Hines, Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression, Nature medicine, vol.17, pp.320-329, 2011.

L. R. Bonser, B. W. Schroeder, L. A. Ostrin, N. Baumlin, J. L. Olson et al., The Endoplasmic Reticulum Resident Protein AGR3. Required for Regulation of Ciliary Beat Frequency in the Airway, American journal of respiratory cell and molecular biology, vol.53, pp.536-543, 2015.

V. Brychtova, B. Vojtesek, and R. Hrstka, Anterior gradient 2: a novel player in tumor cell biology, Cancer letters, vol.304, pp.1-7, 2011.

H. Bu, M. R. Schweiger, T. Manke, A. Wunderlich, B. Timmermann et al., Anterior gradient 2 and 3-two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells, The FEBS journal, vol.280, pp.1249-1266, 2013.
DOI : 10.1111/febs.12118
URL : https://deepblue.lib.umich.edu/bitstream/2027.42/96748/1/febs12118.pdf

A. P. Carvalho, P. A. Fernandes, and M. J. Ramos, Similarities and differences in the thioredoxin superfamily, Progress in biophysics and molecular biology, vol.91, pp.229-248, 2006.
DOI : 10.1016/j.pbiomolbio.2005.06.012

E. Chevet, D. Fessart, F. Delom, A. Mulot, B. Vojtesek et al., Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development, Oncogene, vol.32, pp.2499-2509, 2013.

R. Chrisanthar, S. Knappskog, E. Lokkevik, G. Anker, B. Ostenstad et al., Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel, PloS one, vol.6, p.19249, 2011.

H. Dihazi, Prognosis markers for metastatic renal cell carcinoma: quantitative proteomics approach. Expert review of proteomics, vol.10, pp.21-24, 2013.
DOI : 10.1586/epr.12.71

P. Dobes, J. Podhorec, O. Coufal, A. Jureckova, K. Petrakova et al., Influence of mutation type on prognostic and predictive values of TP53 status in primary breast cancer patients, Oncology reports, vol.32, pp.1695-1702, 2014.

A. Dong, D. Wodziak, and A. W. Lowe, Epidermal growth factor receptor (EGFR) signaling requires a specific endoplasmic reticulum thioredoxin for the post-translational control of receptor presentation to the cell surface, The Journal of biological chemistry, vol.290, pp.8016-8027, 2015.

L. Dumartin, W. Alrawashdeh, S. M. Trabulo, T. P. Radon, K. Steiger et al., ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation, Oncogene, vol.36, pp.3094-3103, 2017.

L. Dumartin, H. J. Whiteman, M. E. Weeks, D. Hariharan, B. Dmitrovic et al.,

. Crnogorac-jurcevic, AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D. Cancer research, vol.71, pp.7091-7102, 2011.

D. Fessart, C. Domblides, T. Avril, L. A. Eriksson, H. Begueret et al., , 2016.

G. C. Fletcher, S. Patel, K. Tyson, P. J. Adam, M. Schenker et al., hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan, British journal of cancer, vol.88, pp.579-585, 2003.

W. H. Fridman, L. Zitvogel, C. Sautes-fridman, and G. Kroemer, The immune contexture in cancer prognosis and treatment, Nature reviews. Clinical oncology, vol.14, pp.717-734, 2017.

P. Gallant, Control of transcription by Pontin and Reptin, Trends in cell biology, vol.17, pp.187-192, 2007.
DOI : 10.1016/j.tcb.2007.02.005
URL : http://www.zora.uzh.ch/id/eprint/385/1/Gallant_Trends_2007.pdf

J. J. Galligan and D. R. Petersen, The human protein disulfide isomerase gene family, Human genomics, vol.6, p.6, 2012.
DOI : 10.1186/1479-7364-6-6
URL : https://humgenomics.biomedcentral.com/track/pdf/10.1186/1479-7364-6-6

A. Galvan, E. Frullanti, M. Anderlini, G. Manenti, S. Noci et al., Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients, Carcinogenesis, vol.34, pp.2767-2773, 2013.

S. Garczyk, S. Stillfried, W. Antonopoulos, A. Hartmann, M. G. Schrauder et al., AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection, PloS one, vol.10, p.122106, 2015.
DOI : 10.1371/journal.pone.0122106
URL : https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0122106&type=printable

T. A. Gray, N. J. Maclaine, C. O. Michie, P. Bouchalova, E. Murray et al., Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models, Journal of immunological methods, vol.378, pp.20-32, 2012.

T. A. Gray, E. Murray, M. W. Nowicki, L. Remnant, A. Scherl et al., Development of a fluorescent monoclonal antibody-based assay to measure the allosteric effects of synthetic peptides on self-oligomerization of AGR2 protein, vol.22, pp.1266-1278, 2013.

H. Guo, Q. Zhu, X. Yu, S. B. Merugu, H. B. Mangukiya et al., Tumor-secreted anterior gradient-2 binds to VEGF and FGF2 and enhances their activities by promoting their homodimerization, Oncogene, vol.36, pp.5098-5109, 2017.
DOI : 10.1038/onc.2017.132

A. Gupta, A. Dong, and A. W. Lowe, AGR2 gene function requires a unique endoplasmic reticulum localization motif, The Journal of biological chemistry, vol.287, pp.4773-4782, 2012.

F. Hatahet and L. W. Ruddock, Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation, Antioxidants & redox signaling, vol.11, pp.2807-2850, 2009.

S. M. Hengel, E. Murray, S. Langdon, L. Hayward, J. O'donoghue et al., Data-independent proteomic screen identifies novel tamoxifen agonist that mediates drug resistance, Journal of proteome research, vol.10, pp.4567-4578, 2011.

C. Hetz, E. Chevet, and S. A. Oakes, Proteostasis control by the unfolded protein response, Nature cell biology, vol.17, pp.829-838, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01175531

A. Higa, A. Mulot, F. Delom, M. Bouchecareilh, D. T. Nguyen et al., Role of pro-oncogenic protein disulfide isomerase (PDI) family member anterior gradient 2 (AGR2) in the control of endoplasmic reticulum homeostasis, The Journal of biological chemistry, vol.286, pp.44855-44868, 2011.

R. Hrstka, R. Nenutil, A. Fourtouna, M. M. Maslon, C. Naughton et al., The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers, Oncogene, vol.29, pp.4838-4847, 2010.

H. E. Innes, D. Liu, R. Barraclough, M. P. Davies, P. A. O'neill et al., Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients, British journal of cancer, vol.94, pp.1057-1065, 2006.

W. Jeong, D. Y. Lee, S. Park, and S. G. Rhee, ERp16, an endoplasmic reticulum-resident thioldisulfide oxidoreductase: biochemical properties and role in apoptosis induced by endoplasmic reticulum stress, The Journal of biological chemistry, vol.283, pp.25557-25566, 2008.

S. Jha and A. Dutta, RVB1/RVB2: running rings around molecular biology, Molecular cell, vol.34, pp.521-533, 2009.

M. Jia, Y. Guo, D. Zhu, N. Zhang, L. Li et al., Pro-metastatic activity of AGR2 interrupts angiogenesis target bevacizumab efficiency via direct interaction with VEGFA and activation of NF-kappaB pathway, Biochimica et biophysica acta, vol.1864, pp.1622-1633, 2018.

F. W. Khwaja, P. Svoboda, M. Reed, J. Pohl, B. Pyrzynska et al., Proteomic identification of the wt-p53-regulated tumor cell secretome, Oncogene, vol.25, pp.7650-7661, 2006.

J. H. Kim, H. J. Choi, B. Kim, M. H. Kim, J. M. Lee et al., Roles of sumoylation of a reptin chromatin-remodelling complex in cancer metastasis, Nature cell biology, vol.8, pp.631-639, 2006.

J. H. Kim, B. Kim, L. Cai, H. J. Choi, K. A. Ohgi et al., Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes, Nature, vol.434, pp.921-926, 2005.

E. R. King, C. S. Tung, Y. T. Tsang, Z. Zu, G. T. Lok et al., The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer, The American journal of surgical pathology, vol.35, pp.904-912, 2011.

E. Lee and D. H. Lee, Emerging roles of protein disulfide isomerase in cancer, BMB reports, vol.50, pp.401-410, 2017.

H. J. Lee, C. Y. Hong, C. J. Jin, M. H. Kim, Y. K. Lee et al., Identification of novel HLA-A*0201-restricted epitopes from anterior gradient-2 as a tumor-associated antigen against colorectal cancer, Cellular & molecular immunology, vol.9, pp.175-183, 2012.

C. T. Leung and J. S. Brugge, Outgrowth of single oncogene-expressing cells from suppressive epithelial environments, Nature, vol.482, pp.410-413, 2012.

Z. Li, Q. Zhu, H. Chen, L. Hu, H. Negi et al., Binding of anterior gradient 2 and estrogen receptor-alpha: Dual critical roles in enhancing fulvestrant resistance and IGF-1-induced tumorigenesis of breast cancer, Cancer letters, vol.377, pp.32-43, 2016.

C. A. Lyssiotis and A. C. Kimmelman, Metabolic Interactions in the Tumor Microenvironment, Trends in cell biology, vol.27, pp.863-875, 2017.

S. R. Ma, W. M. Wang, C. F. Huang, W. F. Zhang, and Z. J. Sun, Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transition, Oncotarget, vol.6, pp.8807-8821, 2015.

N. Maishi and K. Hida, Tumor endothelial cells accelerate tumor metastasis. Cancer science, vol.108, pp.1921-1926, 2017.

M. M. Maslon, R. Hrstka, B. Vojtesek, and T. R. Hupp, A divergent substrate-binding loop within the pro-oncogenic protein anterior gradient-2 forms a docking site for Reptin, Journal of molecular biology, vol.404, pp.418-438, 2010.

E. Meeusen, E. Lim, and S. Mathivanan, Secreted Tumor Antigens-Immune Biomarkers for Diagnosis and Therapy, Proteomics, vol.17, 2017.

I. Mellman and G. Warren, The road taken: past and future foundations of membrane traffic, Cell, vol.100, pp.99-112, 2000.

Y. Mezawa and A. Orimo, The roles of tumor-and metastasis-promoting carcinomaassociated fibroblasts in human carcinomas, Cell and tissue research, vol.365, pp.675-689, 2016.

P. A. Netti, D. A. Berk, M. A. Swartz, A. J. Grodzinsky, and R. K. Jain, Role of extracellular matrix assembly in interstitial transport in solid tumors, Cancer research, vol.60, pp.2497-2503, 2000.

W. Nickel, The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes, European journal of biochemistry, vol.270, pp.2109-2119, 2003.

J. Obacz, V. Brychtova, J. Podhorec, P. Fabian, P. Dobes et al., Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients, OncoTargets and therapy, vol.8, pp.1523-1532, 2015.

J. L. Paltridge, L. Belle, and Y. Khew-goodall, The secretome in cancer progression, Biochimica et biophysica acta, vol.1834, pp.2233-2241, 2013.

J. L. Pan and J. C. Bardwell, The origami of thioredoxin-like folds. Protein science : a publication of the, vol.15, pp.2217-2227, 2006.

S. W. Park, G. Zhen, C. Verhaeghe, Y. Nakagami, L. T. Nguyenvu et al., The protein disulfide isomerase AGR2 is essential for production of intestinal mucus, Proceedings of the National Academy of Sciences of the United States of America, vol.106, pp.6950-6955, 2009.

V. Plaks, N. Kong, and Z. Werb, The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?, Cell stem cell, vol.16, pp.225-238, 2015.

V. Ramachandran, T. Arumugam, H. Wang, and C. D. Logsdon, Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer research, vol.68, pp.7811-7818, 2008.

S. Rashid, A. Pilecka, M. Torun, B. Olchowik, M. Bielinska et al., Endosomal adaptor proteins APPL1 and APPL2 are novel activators of beta-catenin/TCF-mediated transcription, The Journal of biological chemistry, vol.284, pp.18115-18128, 2009.

I. Raykhel, H. Alanen, K. Salo, J. Jurvansuu, V. D. Nguyen et al., A molecular specificity code for the three mammalian KDEL receptors, The Journal of cell biology, vol.179, pp.1193-1204, 2007.

S. S. Shishkin, L. S. Eremina, L. I. Kovalev, and M. A. Kovaleva, AGR2, ERp57/GRP58, and some other human protein disulfide isomerases, Biochemistry. Biokhimiia, vol.78, pp.1415-1430, 2013.

M. H. Vaarala, P. Hirvikoski, S. Kauppila, and T. K. Paavonen, Identification of androgenregulated genes in human prostate, Molecular medicine reports, vol.6, pp.466-472, 2012.

E. G. Van-meir, P. J. Polverini, V. R. Chazin, H. J. Su-huang, N. De-tribolet et al., Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells, Nature genetics, vol.8, pp.171-176, 1994.

P. Walter, R. Gilmore, and G. Blobel, Protein translocation across the endoplasmic reticulum, Cell, vol.38, pp.5-8, 1984.

T. L. Whiteside, The tumor microenvironment and its role in promoting tumor growth, Oncogene, vol.27, pp.5904-5912, 2008.

J. Yuan, P. S. Hegde, R. Clynes, P. G. Foukas, A. Harari et al., Novel technologies and emerging biomarkers for personalized cancer immunotherapy, Journal for immunotherapy of cancer, vol.4, p.3, 2016.
DOI : 10.1186/s40425-016-0107-3
URL : https://jitc.biomedcentral.com/track/pdf/10.1186/s40425-016-0107-3

W. Zheng, P. Rosenstiel, K. Huse, C. Sina, R. Valentonyte et al., Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease, Genes and immunity, vol.7, pp.11-18, 2006.